Evidence map›Paper›PMID 33625866›Full record

ArticleJCO global oncology2021

Factors Associated With Colorectal Cancer Screening Via Immunochemical Fecal Occult Blood Test in an Average-Risk Population From a Multiethnic, Middle-Income Setting.

Nur-Nadiatul-Asyikin Bujang, Yu-Jie Lee, Siti-Anis-Suraya Mohd-Zain, Junita-Harizon Aris, Fitri-Amalina Md-Yusoff, Zailiza Suli, Muhammad-Radzi Abu-Hassan, Nirmala Bhoo-Pathy

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nur-Nadiatul-Asyikin BujangDepartment of Social and Preventive Medicine, Centre for Epidemiology and Evidenced-Based Practice, Faculty of Medicine, Lembah Pantai, Kuala Lumpur, Malaysia.ORCID 0000-0003-1775-539X
Yu-Jie LeeDepartment of Social and Preventive Medicine, Centre for Epidemiology and Evidenced-Based Practice, Faculty of Medicine, Lembah Pantai, Kuala Lumpur, Malaysia.ORCID 0000-0002-6563-9927
Siti-Anis-Suraya Mohd-ZainDepartment of Social and Preventive Medicine, Centre for Epidemiology and Evidenced-Based Practice, Faculty of Medicine, Lembah Pantai, Kuala Lumpur, Malaysia.ORCID 0000-0002-6828-157X
Junita-Harizon ArisBatu 14 Health Clinic, Jalan Hulu Langat, Selangor, Malaysia.ORCID 0000-0002-5000-315X
Fitri-Amalina Md-YusoffBatu 14 Health Clinic, Jalan Hulu Langat, Selangor, Malaysia.
Zailiza SuliHulu Langat District Health Office, Kajang, Selangor, Malaysia.
Muhammad-Radzi Abu-HassanGastroenterology Service, Ministry of Health, Malaysia.
Nirmala Bhoo-PathyDepartment of Social and Preventive Medicine, Centre for Epidemiology and Evidenced-Based Practice, Faculty of Medicine, Lembah Pantai, Kuala Lumpur, Malaysia.ORCID 0000-0003-0568-8863
Ministry of Health · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe Malaysian Ministry of Health had launched free opportunistic screening for colorectal cancer using immunochemical fecal occult blood test (iFOBT) targeting the average-risk individuals since 2014. This study aims to determine factors associated with colorectal cancer screening using iFOBT among the average-risk Malaysian population.

methodsA cross-sectional study was conducted at five government-run health clinics in the state of Selangor. Adults with an average risk of colorectal cancer (age > 50 years, asymptomatic, and no family history of colorectal cancer) were recruited using systematic random sampling. An interviewer-administered questionnaire adapted from the Cancer Awareness Measure and Health Belief Model was used.

resultsThe median age of participants was 61 years (interquartile range, 56 to 66). Almost 60% of participants indicated their willingness to be screened. However, only 7.5% had undergone iFOBT. Good knowledge of risk factors of colorectal cancer, perceived susceptibility to the disease, and the doctor's recommendation were associated with increased willingness to be screened: adjusted odds ratio (aOR), 1.66 (95% CI, 1.12 to 2.46); aOR, 1.70 (95% CI, 1.08 to 2.70); and aOR, 5.76 (95% CI, 2.13 to 15.57), respectively. Nevertheless, being elderly (aOR, 0.67; 95% CI, 0.45 to 0.99) and high negative perception toward the testing method (iFOBT) (aOR, 0.12; 95% CI, 0.05 to 0.30) were independently associated with lower willingness to be screened. Multivariable analysis within the average-risk individuals who were willing to be screened for colorectal cancer showed that the doctor's recommendations remained as an important cue for positive action, whereas negative perception toward the test was a significant barrier to the actual uptake of iFOBT.

conclusionThe present findings must be factored in when tailoring colorectal cancer screening promotion activities in multiethnic, middle-income settings.

Indexed as

Colorectal NeoplasmsOccult BloodAdultAgedCross-Sectional StudiesEarly Detection of CancerHumansMiddle AgedRisk Factors

Identifiers

PMID33625866
PMCPMC8081512
OpenAlexW3129195665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.